Home › Therapeutic areas › Oncology › Gastrointestinal Stromal Tumors
Gastrointestinal Stromal Tumors (2 companies)
Companies with an active program in Gastrointestinal Stromal Tumors.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| COGT | Cogent Biosciences | HematologyOncology Rare | 1 | NDA Submitted | $5.51B | 7 |
| KURA | Kura Oncology | MetabolicOncology | 1 | Approved | $647M | 12 |
No companies match.